Ignite Creation Date:
2025-12-25 @ 3:02 AM
Ignite Modification Date:
2026-02-23 @ 8:56 PM
Study NCT ID:
NCT02440633
Status:
COMPLETED
Last Update Posted:
2016-10-21
First Post:
2015-05-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 1,Open -Label Study to Assess the Absorption, Metabolism and Excretion of 14C-OPS-2071 Following a Single Oral Dose to Healthy Male Japanese Subjects
Sponsor:
Otsuka Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-05
Start Date Type:
None
Primary Completion Date:
2015-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-08
Completion Date Type:
ACTUAL
First Submit Date:
2015-05-01
First Submit QC Date:
None
Study First Post Date:
2015-05-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-07-10
Results First Submit QC Date:
None
Results First Post Date:
2016-08-24
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-08-30
Last Update Post Date:
2016-10-21
Last Update Post Date Type:
ESTIMATED